A panelist discusses how the new doravirine and islatravir combination offers an alternative to integrase inhibitor-based ...

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

Even after decades of research, there is no cure for the disease HIV causes, AIDS. But lenacapavir, born out of research on ...

Patients in historically redlined neighborhoods experience significantly longer delays in achieving HIV viral suppression ...

HIV and Aids campaigns are often targeted at the youth. But new research has found high prevalence rates among older people.

A cross-sectional analysis shows that long-acting antiretroviral therapy sustains viral suppression regardless of initial ...

Tackling HIV continues to be a major public health challenge, mainly because the persistence of viral reservoirs means that people living with HIV need to take lifelong antiretroviral treatment. But ...

Tackling HIV continues to be a major public health challenge, mainly because the persistence of viral reservoirs means that ...

In a move to safeguard healthcare systems amid the recent collapse of USAID-funded supply chains for healthcare commodities, ...

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...

Patients attending Medway Maritime Hospital's A&E will now be routinely tested for HIV and hepatitis unless they opt out. The ...